Skip to main content
Log in

Two-dose hepatitis B vaccine cost effective versus 3-dose vaccine

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2020 US dollars

Reference

  • Hirst A, et al. Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations. Vaccine : 12 May 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2021.05.020

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Two-dose hepatitis B vaccine cost effective versus 3-dose vaccine. PharmacoEcon Outcomes News 880, 32 (2021). https://doi.org/10.1007/s40274-021-7790-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7790-0

Navigation